Inflammation-based lung adenocarcinoma molecular subtype identification and construction of an inflammation-related signature with bulk and single-cell RNA-seq data
The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation...
Saved in:
Published in | Aging (Albany, NY.) Vol. 16; no. 10; pp. 8822 - 8842 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Impact Journals
20.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies. |
---|---|
AbstractList | The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies. The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies.The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However, the detailed molecular divisions involved in inflammatory responses are yet to be fully elucidated. Our study identified two main inflammation-oriented LUAD grades: the inflammation-low (INF-low) and the inflammation-high (INF-high) subtypes. Both presented with unique clinicopathological features, implications for prognosis, and distinctive tumor microenvironment profiles. Broadly, the INF-low grade, marked by its dominant immunosuppressive tumor microenvironment, was accompanied by less favorable prognostic outcomes and a heightened prevalence of oncogenic mutations. In contrast, the INF-high grade exhibited more optimistic clinical trajectories, underscored by its immune-active environment. In addition, our efforts led to the conceptualization and empirical validation of an inflammation-centric predictive model with considerable predictive potency. Our study paves the way for a refined inflammation-centric LUAD classification and fosters a deeper understanding of tumor microenvironment intricacies. |
Author | Bian, Chengyu Fu, Chenghao Xia, Yang Zhang, Wenhao Gu, Yan Wei, Ke Mu, Guang Wang, Jun Wang, Hongchang Xue, Wentao |
Author_xml | – sequence: 1 givenname: Yan surname: Gu fullname: Gu, Yan organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 2 givenname: Chengyu surname: Bian fullname: Bian, Chengyu organization: Department of Thoracic Surgery, The First People’s Hospital of Changzhou and The Third Affiliated Hospital of Soochow University, Changzhou 213004, Jiangsu, China – sequence: 3 givenname: Hongchang surname: Wang fullname: Wang, Hongchang organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 4 givenname: Chenghao surname: Fu fullname: Fu, Chenghao organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 5 givenname: Wentao surname: Xue fullname: Xue, Wentao organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 6 givenname: Wenhao surname: Zhang fullname: Zhang, Wenhao organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 7 givenname: Guang surname: Mu fullname: Mu, Guang organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 8 givenname: Yang surname: Xia fullname: Xia, Yang organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 9 givenname: Ke surname: Wei fullname: Wei, Ke organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China – sequence: 10 givenname: Jun surname: Wang fullname: Wang, Jun organization: Department of Thoracic Surgery, Jiangsu Province Hospital and the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38771142$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkUlvFTEQhC0URJIHR67IRy4T7LE9ywlFEUukCCQEZ6vHy8TgsV-8gPJ_-KEM80L0ONnq_rpKpTpHJyEGg9BLSi7o0LH2DcwuzBctEQMnT9AZHblouBjGk6P_KTrP-TshnRC8e4ZO2dD3lPL2DP2-DtbDskBxMTQTZKOxr2HGoE2ICpJyIS6Al-iNqh4SznUq93uD3QoUZ53aTjEEjVUMuaSqtkG06wy7Y_lkPJTVILs5QKnJ4F-u3OKp-h_bfV6TeNMo4z3-8umyyeYOayjwHD214LN58fDu0Lf3775efWxuPn-4vrq8aRTjvDRq4FqbNRgIaJkRrCe8J4z3HbGDJYS1SjE9WtuOHVHtNHW9HRSdqNBaKd2xHXp70N3XaTFarQETeLlPboF0LyM4-f8muFs5x5-SUtpxsTrs0OsHhRTvqslFLi7_zQPBxJolI6LvRib6cUVfHZs9uvzrZgWaA6BSzDkZ-4hQIrfu5da9PHTP_gCzKaem |
Cites_doi | 10.1158/0008-5472.CAN-20-1994 10.1016/S0140-6736(16)30958-8 10.1158/0008-5472.CAN-18-0689 10.1038/nature25501 10.1016/j.celrep.2016.12.019 10.1038/s41467-020-16164-1 10.1093/nar/gkaa1020 10.1016/j.cell.2014.12.033 10.1038/nature07205 10.1016/j.tcb.2018.02.004 10.1038/s41467-021-26770-2 10.1183/13993003.00359-2016 10.1158/2326-6066.CIR-18-0822 10.3322/caac.21763 10.1038/s41591-018-0136-1 10.3390/cancers13030384 10.1038/s41423-020-0488-6 10.3322/caac.21660 10.1016/S1470-2045(14)70263-3 10.1038/ni.2060 10.1038/s41423-021-00756-y 10.3390/ijms22115421 10.1002/jcsm.13032 10.1002/phar.2663 10.1038/nature20123 10.1146/annurev-cellbio-100913-013325 10.1007/978-1-4939-7493-1_12 10.1038/s41392-021-00824-9 10.1093/bib/bbaa164 10.1038/nri.2017.142 10.1002/cac2.12025 10.1136/jitc-2021-003534 |
ContentType | Journal Article |
Copyright | Copyright: © 2024 Gu et al. |
Copyright_xml | – notice: Copyright: © 2024 Gu et al. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.18632/aging.205840 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1945-4589 |
EndPage | 8842 |
ExternalDocumentID | PMC11164500 38771142 10_18632_aging_205840 |
Genre | Journal Article |
GroupedDBID | --- 53G AAYXX ADBBV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z FRP GX1 HYE KQ8 M48 O5R O5S OK1 PGMZT RPM W2D CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c344t-c84dde711a5a23e537047034760f8f0032cc3d9ff2960c2bb67f8c1b15ddccd63 |
IEDL.DBID | M48 |
ISSN | 1945-4589 |
IngestDate | Thu Aug 21 18:33:45 EDT 2025 Fri Jul 11 05:51:52 EDT 2025 Thu Apr 03 07:00:58 EDT 2025 Tue Jul 01 00:42:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 10 |
Keywords | molecular subtypes immune tumor microenvironment inflammation lung adenocarcinoma |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c344t-c84dde711a5a23e537047034760f8f0032cc3d9ff2960c2bb67f8c1b15ddccd63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Equal contribution |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.18632/aging.205840 |
PMID | 38771142 |
PQID | 3057693579 |
PQPubID | 23479 |
PageCount | 21 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11164500 proquest_miscellaneous_3057693579 pubmed_primary_38771142 crossref_primary_10_18632_aging_205840 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20240520 |
PublicationDateYYYYMMDD | 2024-05-20 |
PublicationDate_xml | – month: 5 year: 2024 text: 20240520 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Aging (Albany, NY.) |
PublicationTitleAlternate | Aging (Albany NY) |
PublicationYear | 2024 |
Publisher | Impact Journals |
Publisher_xml | – name: Impact Journals |
References | Cuculich (11) 2022; 4 Karin (29) 2011; 1 Jülicher (31) 2014; 3 Balkwill (14) 2008; 45 Alizadeh (19) 2018; 171 Zhang (24) 2021; 4 Bray (1) 2021; 7 Stathopoulos (15) 2021; 1 Paz-Ares (7) 2017; 38 Zhang (16) 2020; 1 Karin (30) 2018; 1 Yarchoan (20) 2019; 7 Di (9) 2021; 8 Yang (10) 2022; 1 Li (22) 2018; 7 Taniguchi (13) 2021; 2 Guo (4) 2021; 1 Trajanoski (21) 2017; 1 Boffetta (8) 2016; 4 Joung (17) 2020; 1 Li (5) 2022; 7 Zhou (6) 2022; 1 Clarke (25) 2014; 1 Jemal (2) 2023; 7 Nyman (23) 2016; 53 Hacohen (27) 2015; 16 Brown (26) 2018; 2 Dai (28) 2021; 2 Shalapour (12) 2022; 1 Yang (18) 2018; 55 Fuxreiter (32) 2018; 2 Chen (3) 2020; 4 |
References_xml | – volume: 8 start-page: 144 year: 2021 ident: 9 article-title: Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen-Induced Lung Cancer and Determines the Efficacy of Immunotherapy. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-20-1994 – volume: 38 start-page: 299 year: 2017 ident: 7 article-title: Lung cancer: current therapies and new targeted treatments. publication-title: Lancet doi: 10.1016/S0140-6736(16)30958-8 – volume: 7 start-page: 6575 year: 2018 ident: 22 article-title: TIP: A Web Server for Resolving Tumor Immunophenotype Profiling. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-18-0689 – volume: 55 start-page: 544 year: 2018 ident: 18 article-title: TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. publication-title: Nature doi: 10.1038/nature25501 – volume: 1 start-page: 248 year: 2017 ident: 21 article-title: Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. publication-title: Cell Rep doi: 10.1016/j.celrep.2016.12.019 – volume: 1 start-page: 2285 year: 2020 ident: 17 article-title: Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. publication-title: Nat Commun doi: 10.1038/s41467-020-16164-1 – volume: 4 start-page: D1420 year: 2021 ident: 24 article-title: TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa1020 – volume: 16 start-page: 48 year: 2015 ident: 27 article-title: Molecular and genetic properties of tumors associated with local immune cytolytic activity. publication-title: Cell doi: 10.1016/j.cell.2014.12.033 – volume: 45 start-page: 436 year: 2008 ident: 14 article-title: Cancer-related inflammation. publication-title: Nature doi: 10.1038/nature07205 – volume: 2 start-page: 420 year: 2018 ident: 32 article-title: Protein Phase Separation: A New Phase in Cell Biology. publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2018.02.004 – volume: 1 start-page: 6500 year: 2021 ident: 4 article-title: Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing. publication-title: Nat Commun doi: 10.1038/s41467-021-26770-2 – volume: 4 start-page: 889 year: 2016 ident: 8 article-title: Risk factors for lung cancer worldwide. publication-title: Eur Respir J doi: 10.1183/13993003.00359-2016 – volume: 7 start-page: 886 year: 2019 ident: 20 article-title: Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival. publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.CIR-18-0822 – volume: 7 start-page: 17 year: 2023 ident: 2 article-title: Cancer statistics, 2023. publication-title: CA Cancer J Clin doi: 10.3322/caac.21763 – volume: 2 start-page: 1550 year: 2018 ident: 26 article-title: Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. publication-title: Nat Med doi: 10.1038/s41591-018-0136-1 – volume: 1 start-page: 384 year: 2021 ident: 15 article-title: Immune Resistance in Lung Adenocarcinoma. publication-title: Cancers (Basel) doi: 10.3390/cancers13030384 – volume: 1 start-page: 807 year: 2020 ident: 16 article-title: The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. publication-title: Cell Mol Immunol doi: 10.1038/s41423-020-0488-6 – volume: 7 start-page: 209 year: 2021 ident: 1 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 1 start-page: e493 year: 2014 ident: 25 article-title: Cancer-related inflammation and treatment effectiveness. publication-title: Lancet Oncol doi: 10.1016/S1470-2045(14)70263-3 – volume: 1 start-page: 715 year: 2011 ident: 29 article-title: Inflammation meets cancer, with NF-κB as the matchmaker. publication-title: Nat Immunol doi: 10.1038/ni.2060 – volume: 1 start-page: 59 year: 2022 ident: 12 article-title: Regulation of antitumor immunity by inflammation-induced epigenetic alterations. publication-title: Cell Mol Immunol doi: 10.1038/s41423-021-00756-y – volume: 2 start-page: 5421 year: 2021 ident: 13 article-title: Inflammation-Induced Tumorigenesis and Metastasis. publication-title: Int J Mol Sci doi: 10.3390/ijms22115421 – volume: 1 start-page: 2504 year: 2022 ident: 10 article-title: The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. publication-title: J Cachexia Sarcopenia Muscle doi: 10.1002/jcsm.13032 – volume: 4 start-page: 250 year: 2022 ident: 11 article-title: The role of inflammation in the pathogenesis and treatment of arrhythmias. publication-title: Pharmacotherapy doi: 10.1002/phar.2663 – volume: 53 start-page: 309 year: 2016 ident: 23 article-title: Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. publication-title: Nature doi: 10.1038/nature20123 – volume: 3 start-page: 39 year: 2014 ident: 31 article-title: Liquid-liquid phase separation in biology. publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev-cellbio-100913-013325 – volume: 171 start-page: 243 year: 2018 ident: 19 article-title: Profiling Tumor Infiltrating Immune Cells with CIBERSORT. publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-7493-1_12 – volume: 7 start-page: 9 year: 2022 ident: 5 article-title: Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer. publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00824-9 – volume: 2 start-page: bbaa164 year: 2021 ident: 28 article-title: Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology. publication-title: Brief Bioinform doi: 10.1093/bib/bbaa164 – volume: 1 start-page: 309 year: 2018 ident: 30 article-title: NF-κB, inflammation, immunity and cancer: coming of age. publication-title: Nat Rev Immunol doi: 10.1038/nri.2017.142 – volume: 4 start-page: 205 year: 2020 ident: 3 article-title: Cancer burden of major cancers in China: A need for sustainable actions. publication-title: Cancer Commun (Lond) doi: 10.1002/cac2.12025 – volume: 1 start-page: e003534 year: 2022 ident: 6 article-title: Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. publication-title: J Immunother Cancer doi: 10.1136/jitc-2021-003534 |
SSID | ssj0065546 |
Score | 2.3730178 |
Snippet | The role of inflammation is increasingly understood to have a central influence on therapeutic outcomes and prognosis in lung adenocarcinoma (LUAD). However,... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 8822 |
SubjectTerms | Adenocarcinoma of Lung - genetics Adenocarcinoma of Lung - immunology Adenocarcinoma of Lung - pathology Aged Female Gene Expression Regulation, Neoplastic Humans Inflammation - genetics Lung Neoplasms - genetics Lung Neoplasms - immunology Lung Neoplasms - pathology Male Middle Aged Prognosis Research Paper RNA-Seq Single-Cell Analysis Single-Cell Gene Expression Analysis Tumor Microenvironment - genetics Tumor Microenvironment - immunology |
Title | Inflammation-based lung adenocarcinoma molecular subtype identification and construction of an inflammation-related signature with bulk and single-cell RNA-seq data |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38771142 https://www.proquest.com/docview/3057693579 https://pubmed.ncbi.nlm.nih.gov/PMC11164500 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB61IBAXVKCPpS0yUtVbqONn9oAqVBUoEhyqrrS3yHZisepuUlhWKv-nP5SZJLuw0BOXHBKPo_jLvOx5AHwylGGtQ0xSiRflOE889TeJzsTM9gOZHBRtcWFOB-psqIf3JYW6BZz-17WjflKD6_HB36vbr8jwh8TwmZHiS9PPB309VKbova-iUrLEo-dqcaBgKBirK7H5hGQD1mVmLWWVLmunJybn48jJB6ro-BVsdjYkO2pB34IXZbUNa21XydttWD_vzst34N-PKiLkbXpiQhqrYGNkb-ZQ3KAWu8Zh9cSxybxJLpvOPO3KslHRhRE1pMxVBQv1fbVZVke8x0YPp2_SYvAFFBLSlAtltMnL_Gz8u6GnXYlxmdBRAft5cZRMyytGAaqvYXD8_de306Try5AEqdRNEjKFQhHXy2knZKml5QoFh7KGxyyimBAhyKIfo0D3KAjvjY1ZSH2qiyKEwsg3sFLVVfkOWOq1RZuDB-el8kJnXPRTVwrlZRFscD34PMcj_9OW38jJbSEM8wbDvMWwB_tztHJkEPoUV5X1bJqjQKN-j9r2e_C2RW8x1Rz2HmRLuC4GUPHt5SfV6LIpwo06wijN-e7zSd_DhkATiWIRBP8AKwhh-RFNnBu_By9Phule8wvfASbpAsk |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammation-based+lung+adenocarcinoma+molecular+subtype+identification+and+construction+of+an+inflammation-related+signature+with+bulk+and+single-cell+RNA-seq+data&rft.jtitle=Aging+%28Albany%2C+NY.%29&rft.au=Gu%2C+Yan&rft.au=Bian%2C+Chengyu&rft.au=Wang%2C+Hongchang&rft.au=Fu%2C+Chenghao&rft.date=2024-05-20&rft.pub=Impact+Journals&rft.eissn=1945-4589&rft.volume=16&rft.issue=10&rft.spage=8822&rft.epage=8842&rft_id=info:doi/10.18632%2Faging.205840&rft_id=info%3Apmid%2F38771142&rft.externalDocID=PMC11164500 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1945-4589&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1945-4589&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1945-4589&client=summon |